A recent study found that JAK inhibitors don’t increase the risk of cardiac problems
Rates of venous thromboembolism (VTE) were also similar (adjusted HR 1.1, 95% CI 0.7-1.6) in the study of nearly 16,000 rheumatoid arthritis patients, the researchers reported in Annals of the Rheumatic Diseases. An examination of French national registry data revealed that patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis had cardiovascular results comparable to those of […]
